Skip to main content
. 2010 Dec 15;93(2):402–412. doi: 10.3945/ajcn.110.005611

TABLE 4.

Plasma phenylalanine, leucine, and glucose concentrations and phenylalanine and glucose tracer-to-tracee ratios (TTR) during basal, postabsorptive conditions and during the hyperinsulinemic-hyperaminoacidemic clamp before and after omega-3 fatty acid supplementation (n = 8)1

Concentration2
Enrichment (TTR)
Phenylalanine
Leucine
Glucose
Phenylalanine
Glucose
Time Before After Before After Before After Before After Before After
μmol/L μmol/L mmol/L
Basal conditions
 60 min 58 ± 10 61 ± 14 112 ± 11 117 ± 7 5.03 ± 0. 10 5.29 ± 0.07 0.0853 ± 0.0040 0.0914 ± 0.0093
 90 min 63 ± 9 57 ± 9 119 ± 8 111 ± 6 0.0854 ± 0.0078 0.0968 ± 0.0073
 120 min 56 ± 9 58 ± 10 107 ± 8 109 ± 7 5.06 ± 0.10 5.31 ± 0.08 0.0950 ± 0.0065 0.0987 ± 0.0071
 150 min 58 ± 9 57 ± 12 112 ± 10 103 ± 9 0.0962 ± 0.0057 0.0991 ± 0.0084
 180 min 54 ± 9 49 ± 5 104 ± 8 107 ± 6 5.06 ± 0.09 5.41 ± 0.10 0.0999 ± 0.0050 0.1086 ± 0.0062
 210 min 59 ± 8 52 ± 8 116 ± 8 106 ± 5 4.99 ± 0.10 5.30 ± 0.11 0.1014 ± 0.0047 0.1023 ± 0.0062 0.0220 ± 0.0008 0.0218 ± 0.0009
 220 min 4.99 ± 0.09 5.31 ± 0.10 0.0024 ± 0.0009 0.0218 ± 0.0009
 230 min 4.97 ± 0.09 5.28 ± 0.09 0.0225 ± 0.0009 0.0217 ± 0.0009
 240 min 55 ± 7 50 ± 7 110 ± 9 98 ± 7 4.97 ± 0.10 5.29 ± 0.11 0.1038 ± 0.0069 0.1044 ± 0.0055 0.0225 ± 0.0009 0.0217 ± 0.0009
 Mean ± SEM 57 ± 8 56 ± 10 111 ± 7 108 ± 5 5.01 ± 0.09 5.31 ± 0.093 0.0955 ± 0.0052 0.0994 ± 0.0069 0.0223 ± 0.0090 0.0217 ± 0.0090
Hyperinsulinemic-hyperaminoacidemic clamp
 270 min 89 ± 9 91 ± 12 185 ± 10 183 ± 13 5.09 ± 0.18 5.37 ± 0.14 0.1015 ± 0.0030 0.0988 ± 0.0043
 300 min 91 ± 9 95 ± 11 165 ± 9 172 ± 14 5.30 ± 0.17 5.46 ± 0.11 0.0939 ± 0.0024 0.0937 ± 0.0031
 330 min 98 ± 13 99 ± 13 159 ± 12 158 ± 12 5.55 ± 0.06 5.48 ± 0.04 0.0917 ± 0.0032 0.0910 ± 0.0049
 360 min 113 ± 14 109 ± 20 178 ± 18 160 ± 19 5.62 ± 0.09 5.39 ± 0.10 0.0914 ± 0.0036 0.0881 ± 0.0041
 390 min 116 ± 16 108 ± 16 171 ± 10 146 ± 6 5.41 ± 0.07 5.39 ± 0.06 0.0866 ± 0.0076 0.0865 ± 0.0074 0.0260 ± 0.0005 0.0259 ± 0.0007
 400 min 5.46 ± 0.04 5.47 ± 0.07 0.0260 ± 0.0005 0.0264 ± 0.0007
 410 min 5.49 ± 0.06 5.48 ± 0.05 0.0264 ± 0.0005 0.0268 ± 0.0008
 420 min 103 ± 15 101 ± 11 152 ± 13 150 ± 10 5.43 ± 0.04 5.41 ± 0.06 0.0894 ± 0.0052 0.0905 ± 0.0040 0.0264 ± 0.0005 0.0266 ± 0.0007
 Mean ± SEM 102 ± 124 101 ± 134 168 ± 94 161 ± 104 5.42 ± 0.054 5.41 ± 0.044 0.0924 ± 0.0037 0.0914 ± 0.0039 0.0262 ± 0.00504 0.0264 ± 0.00704
1

All values are means ± SEMs. ANOVA on the “before” values from Tables 3 and 4 with group (corn oil compared with omega-3 fatty acid) and study stage (basal compared with clamp) as the factors showed no significant between-group differences (all P ≥ 0.10) or group × study stage interactions (all P ≥ 0.36).

2

With the exception of the change in basal plasma glucose concentration in the omega-3 fatty acid group (P < 0.05 compared with the before-after change in basal plasma glucose concentration in the corn oil group), there were no significant differences in the before-after changes between the corn oil and the omega-3 fatty acid groups.

3

Significantly different from corresponding “before” value, P < 0.05 [ANOVA on values from the omega-3 fatty acid group presented here with study stage (basal compared with clamp) and time (before compared with after intervention) as factors and Tukey's post hoc analysis].

4

Significantly different from corresponding basal value, P < 0.001 [ANOVA on values from the omega-3 fatty acid group presented here with study stage (basal compared with clamp) and time (before compared with after intervention) as factors].